BMC should conduct 20,000 COVID test in a single day ; COVID Task Force

▴ BMC should conduct 20,000 COVID test in a single day ; COVID Task Force
BMC should follow a more aggressive strategy to keep the situation under control during festive season

Relaxation of lockdown restrictions during festive season COVID task force wants BMC should increase the COVID test to 20,000 per day. Though the city is witnessing a dip in the daily cases, however, due to the festive season BMC should follow a more aggressive strategy to keep the situation under control.

Dr Sanjay Oak, head of the COVID task force recommended that per day no testing should be increased, testing kiosks made available at the various part of the city. A drive-in testing facility for COVID-19 has to be arranged. State Govt should take initiative to distribute free masks through the kiosks or fix a nominal price for the masks.

On the other hand, BMC has also confirmed that they have increased the testing facility from 13,000 to 20,000 per day. Last 2 weeks BMC is conducting 20,000 tests in a day.

Dr Oak has further suggested that citizens that to curb the infection we must not gather during festivals not even in a small group. Masking, proper sanitization, and follow social distancing are the only means to avoid this infection.

In a meeting municipal commissioner, Iqbal Singh Chahal has instructed to meet daily targets of testing. He has confirmed that a mix of RT-PCR and antigen tests is the BMC's current testing strategy.

Tags : #BMC #COVIDTest #LatestCOVIDNews20thOct #DrSanjayOak #IqbalSinghChahal

About the Author


Team Medicircle

Related Stories

26 Feb

Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks So

Will the government take responsibility, or will affected families be left fighting a lonely legal battle? The coming weeks will determine the course of justice for those who lost loved ones in the fight against COVID-19.

View
23 Jan

Why India’s Vaccine Industry Struggles to Fund Innovation Despite Global Demand

Affordability ensures accessibility, but innovation determines its effectiveness. India, as a global leader in vaccine production, has a responsibility to balance these two aspects.

View
03 Jan

China’s New Viral Menace: Is HMPV the Next COVID-19?

While HMPV may not have the same catastrophic impact as the coronavirus, its ability to cause severe respiratory illness in vulnerable populations should not be underestimated.

View
15 Nov

A Preventable Catastrophe: Why Are Children Still Dying from Measles?

Governments must step up their efforts, healthcare systems must become more resilient, and communities must rally together to protect their children.

View
09 Nov

The Deadly 17: WHO’s Vaccine Priority List to Tackle Life-Threatening Infections

By focusing on these 17 high-priority pathogens, WHO is leading the way for a world that is better prepared, more resilient, and healthier for all.

View
06 Sep

The Complex Battle Against Polio: How India’s Vaccination Efforts Address Rare Vaccine-Derived Cases

Vaccine-derived poliovirus cases are extremely rare but can occur when the weakened strain of the poliovirus contained in the oral polio vaccine (OPV) mutates and regains its ability to cause disease.

View
16 Aug

A Giant Leap in India’s Fight Against Dengue: Phase 3 Vaccine Trial Launched

This trial not only aims to protect the population but also reinforces India’s capability to produce cutting-edge healthcare solutions, furthering the nation’s goal of self-reliance in essential medical innovations.

View
16 Nov

Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India Launch

As Valneva works towards making this groundbreaking vaccine available in India, the collaboration with CEPI and Instituto Butantan underlines the global effort to address infectious diseases. The upcoming regulatory interactions with DCGI will shed light on the timeline for Ixchiq's launch in India.

View
11 Nov

Historic Breakthrough: FDA Grants Accelerated Approval for Valneva’s Ixchiq - The First Chikungunya Vaccine

As the vaccine moves towards global markets, its impact on public health is poised to be substantial. The ongoing commitment to safety studies and pediatric evaluations reflects a dedication to comprehensive healthcare solutions. The pharmaceutical landscape is witnessing a transformative moment, and Ixchiq stands at the forefront of this medical breakthrough.

View
28 Oct

Spike in Cases of Auto-Immune Disorders like Rheumatoid Arthritis Post-COVID

It looks like the Coronavirus infection has altered our immune system, leading to a variety of health problems like arthritis. Many Covid patients are now coming to us complaining of joint and body pain. We are especially seeing a rise in cases of rheumatoid arthritis among women between 30-50 years of age.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025